DYSLIPIDEMIA

Clinical trials for DYSLIPIDEMIA explained in plain language.

Never miss a new study

Get alerted when new DYSLIPIDEMIA trials appear

Sign up with your email to follow new studies for DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 14 Not yet recruiting 20 Not yet finished but already full! 9 Completed 12 Terminated 1

Heart drug study for diabetes stopped early: what happened?

Disease control Terminated

This study tested a drug called pemafibrate in over 10,000 people with type 2 diabetes and high triglycerides. The goal was to see if it could prevent heart attacks, strokes, or heart-related death. The study was stopped early, and results are being analyzed.

Matched conditions: DYSLIPIDEMIA

Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control

Last updated May 08, 2026 12:01 UTC

DYSLIPIDEMIA

Get alerted when new DYSLIPIDEMIA trials appear

Heart drug study for diabetes stopped early: what happened?